In accordance with these findings, Pierini et al. reported that in vitro TNF priming in the presence of IL2 enhances TNFR2-dependent murine Treg activation and proliferation resulting in Tregs providing superior protection from GvHD (95). Here, TNF is linked to graft versus host disease.